Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
The Cost Differential Between Warfarin Versus Aspirin Treatment After a Fontan Procedure.
Schilling C, Dalziel K, Iyengar AJ, d'Udekem Y. Schilling C, et al. Heart Lung Circ. 2017 Aug;26(8):e44-e47. doi: 10.1016/j.hlc.2017.02.003. Epub 2017 Mar 6. Heart Lung Circ. 2017. PMID: 28372885
BACKGROUND: The use of aspirin versus warfarin for treatment of patients after a Fontan procedure remains contentious. ...METHODS: We combine data from the Australian and New Zealand Fontan Registry and a home INR (International Normalised Ratio) monitoring p …
BACKGROUND: The use of aspirin versus warfarin for treatment of patients after a Fontan procedure remains contentious. …
Warfarin and Aspirin Use for Stroke Prevention Among Patients With Atrial Fibrillation: The US National Health and Wellness Survey.
Goren A, Liu X, Gupta S, Simon TA, Phatak H. Goren A, et al. Am J Ther. 2015 Jul-Aug;22(4):248-56. doi: 10.1097/MJT.0000000000000001. Am J Ther. 2015. PMID: 24326696
Vitamin K antagonist (VKA) and aspirin (ASA) are recommended for stroke prevention in patients with atrial fibrillation (AF). ...Adjusting for covariates in logistic regressions, CHADS2 1 was associated with VKA and/or ASA (vs. non-VKA/ASA) use (P 0.02), but CHADS2 score d …
Vitamin K antagonist (VKA) and aspirin (ASA) are recommended for stroke prevention in patients with atrial fibrillation (AF). ...Adju …